Europe — EMA

Paclitaxel Actavis

Paclitaxel, the active ingredient in Paclitaxel Actavis, is a taxane presented as a unknown/unknown for intravenous use. It treats various cancers and is administered in clinical oncology settings.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Actavis, is a taxane presented as a unknown/unknown for intravenous use. It treats various cancers and is administered in clinical oncology settings. GNH USA supplies Paclitaxel Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is used in oncology to interfere with the cell division process of solid tumors. - Breast cancer: Improves the overall response rate when combined with other chemotherapy agents. - Non‑small cell lung cancer: Enhances treatment outcomes in patients with advanced disease by stabil the micro‑t t --- --- ---

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →